CRON Stock Overview Operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. More details
Rewards Risk Analysis No risks detected for CRON from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Cronos Group Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Cronos Group Historical stock prices Current Share Price CA$2.80 52 Week High CA$4.28 52 Week Low CA$2.56 Beta 1.04 1 Month Change -4.44% 3 Month Change -2.44% 1 Year Change 1.08% 3 Year Change -43.78% 5 Year Change -68.25% Change since IPO 237.35%
Recent News & Updates
President exercised options and sold CA$183k worth of stock Dec 17
Forecast to breakeven in 2025 Dec 05
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 14
Consensus revenue estimates increase by 12%, EPS downgraded Nov 13
Consensus EPS estimates upgraded to US$0.074 loss Oct 01
Cronos Group Inc. Announces Lord Jones Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada Aug 28 See more updates
President exercised options and sold CA$183k worth of stock Dec 17
Forecast to breakeven in 2025 Dec 05
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 14
Consensus revenue estimates increase by 12%, EPS downgraded Nov 13
Consensus EPS estimates upgraded to US$0.074 loss Oct 01
Cronos Group Inc. Announces Lord Jones Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada Aug 28
No longer forecast to breakeven Aug 12
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 09
Consensus EPS estimates fall by 10% Jul 12
No longer forecast to breakeven Jul 11
Consensus EPS estimates fall by 93% Jul 01
Cronos Group Inc. Brand Spinach®? Celebrates Summer with New Launches Jun 28
Cronos Group Inc. Elects Murray Garnick as Director Jun 22
We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow May 31
Forecast breakeven date moved forward to 2025 May 12
First quarter 2024 earnings: EPS and revenues exceed analyst expectations May 10
Consensus EPS estimates upgraded to US$0.036 loss May 07
No longer forecast to breakeven May 07
Consensus EPS estimates fall by 24% Apr 16
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce Apr 01
Cronos Group Inc., Annual General Meeting, Jun 20, 2024 Mar 28
Consensus EPS estimates upgraded to US$0.037 loss Mar 26
Cronos Group Inc. Launches Lord Jones Chocolate Fusions Mar 26
President exercised options and sold CA$232k worth of stock Mar 20
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 03
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth Mar 02
Consensus EPS estimates fall by 44% Mar 02
Revenues Tell The Story For Cronos Group Inc. (TSE:CRON) Feb 02
Forecast to breakeven in 2026 Dec 31
President exercised options and sold CA$169k worth of stock Dec 17
Cronos Group Inc. Announces Launch of Its Highly Anticipated Lord Jones Live Resin Vapes in Two Different Hardware Options Dec 15
Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million. Nov 29
Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million. Nov 28
Forecast to breakeven in 2025 Nov 11
Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.098 loss in 3Q 2022) Nov 10
Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth Nov 09
Cronos Group Inc. Launches Its Cannabis Brand Lord Jones in the Canadian Adult-Use Cannabis Market Nov 04
Cronos Group Inc. Unveils Its New THCV Products: Spinach FEELZ™? Full Tilt Oct 31
Consensus revenue estimates decrease by 14%, EPS upgraded Aug 15
Cronos Group Inc. Revises Earnings Guidance for the Full Year 2023 Aug 10
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Aug 08
We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely Jul 17
Cronos Reportedly Explores Possible Sale After Attracting Takeover Interest Jul 07
Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors Jun 20
Cronos Group Inc. Announces Executive Changes May 20
President exercised options and sold CA$63k worth of stock May 16
Consensus EPS estimates upgraded to US$0.14 loss, revenue downgraded May 16
Price target decreased by 8.6% to CA$3.78 May 15
Cronos Group Inc. Provides Revenue Guidance for the Full Year 2023 May 10
First quarter 2023 earnings: EPS and revenues miss analyst expectations May 10
Consensus revenue estimates decrease by 11%, EPS upgraded Mar 07
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 01
Price target decreased by 11% to CA$4.58 Feb 16
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth Feb 09
Insufficient new directors Jan 24
Cronos Unveils Its New CBC Product: Spinach FEELZ™ Day Trip Gummies with THC+CBC Dec 08
Cronos Group Inc Announces Executive Changes Nov 15
Cronos Group Inc. Announces Final Settlement Agreements with U.S. Securities and Exchange Commission and the Staff of the Ontario Securities Commission Oct 25
Cronos Group Inc. Announces Executive Changes Oct 19
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON) Oct 12
Insufficient new directors Oct 02
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate Sep 10
President exercised options and sold CA$58k worth of stock Aug 28
Independent Director exercised options and sold CA$654k worth of stock Aug 25
Insider exercised options and sold CA$301k worth of stock Aug 19
Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report Aug 12
Second quarter 2022 earnings: Revenues miss analyst expectations Aug 10
Consensus forecasts updated May 20
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth May 19 Cronos Group Inc., Annual General Meeting, Jun 23, 2022 Mar 31
Cronos Group Inc., Annual General Meeting, Jun 23, 2022 Mar 30 Cronos Group Inc. announced delayed amended 10-Q filing
Price target decreased to CA$6.67 Feb 10
General Manager of Canada & Europe exercised options to buy CA$556k worth of stock. Oct 08
Second quarter 2021 earnings released: EPS US$0.15 (vs US$0.31 loss in 2Q 2020) Aug 10
Consensus forecasts updated Aug 07
Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount? Jul 29
Executive Officer Puneet Mathur has left the company Jul 13
Price target decreased to CA$8.99 May 16
Insider exercised options and sold CA$61k worth of stock May 15
Consensus revenue estimates fall to US$69.9m May 14
First quarter 2021 earnings released: US$0.43 loss per share (vs US$0.22 profit in 1Q 2020) May 09
An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued Apr 08
Executive Chairman recently sold CA$7.8m worth of stock Mar 17
Kristen Bell’s Happy Dance™ Available Now at Ulta Beauty™ Mar 16
Executive Chairman exercised options and sold CA$6.6m worth of stock Mar 16
Executive Chairman exercised options and sold CA$7.5m worth of stock Mar 11
Price target raised to CA$9.50 Mar 04
Insider recently sold CA$77k worth of stock Mar 04
Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently? Mar 04
Price target raised to CA$9.10 Mar 02
Analysts update estimates Mar 01
Full year 2020 earnings released: US$0.20 loss per share (vs US$3.76 profit in FY 2019) Feb 27
Revenue beats expectations, earnings disappoint Feb 27 Shareholder Returns CRON CA Pharmaceuticals CA Market 7D -2.1% -1.1% -0.5% 1Y 1.1% -32.0% 14.9%
See full shareholder returns
Return vs Market: CRON underperformed the Canadian Market which returned 14.9% over the past year.
Price Volatility Is CRON's price volatile compared to industry and market? CRON volatility CRON Average Weekly Movement 7.1% Pharmaceuticals Industry Average Movement 12.1% Market Average Movement 8.1% 10% most volatile stocks in CA Market 17.2% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: CRON has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: CRON's weekly volatility (7%) has been stable over the past year.
About the Company Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Show more Cronos Group Inc. Fundamentals Summary How do Cronos Group's earnings and revenue compare to its market cap? CRON fundamental statistics Market cap CA$1.09b Earnings (TTM ) -CA$68.28m Revenue (TTM ) CA$159.69m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) CRON income statement (TTM ) Revenue US$111.23m Cost of Revenue US$87.81m Gross Profit US$23.42m Other Expenses US$70.98m Earnings -US$47.56m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.12 Gross Margin 21.06% Net Profit Margin -42.76% Debt/Equity Ratio 0%
How did CRON perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 05:49 End of Day Share Price 2024/12/30 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Cronos Group Inc. is covered by 19 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Vahan Ajamian Beacon Securities Limited Tamy Chen BMO Capital Markets Equity Research Lisa Lewandowski BofA Global Research
Show 16 more analysts 
